UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $858,000 Stock Holdings in Nu Skin Enterprises, Inc. (NYSE:NUS)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) by 3.7% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 116,424 shares of the company’s stock after buying an additional 4,125 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in Nu Skin Enterprises were worth $858,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of NUS. Pacer Advisors Inc. bought a new stake in Nu Skin Enterprises during the second quarter worth about $25,230,000. Federated Hermes Inc. raised its position in shares of Nu Skin Enterprises by 111.8% in the 2nd quarter. Federated Hermes Inc. now owns 1,323,542 shares of the company’s stock valued at $13,950,000 after buying an additional 698,722 shares in the last quarter. Bank of New York Mellon Corp lifted its holdings in shares of Nu Skin Enterprises by 5.1% during the 2nd quarter. Bank of New York Mellon Corp now owns 901,098 shares of the company’s stock worth $9,498,000 after acquiring an additional 43,935 shares during the period. American Century Companies Inc. boosted its position in shares of Nu Skin Enterprises by 21.0% during the 2nd quarter. American Century Companies Inc. now owns 565,079 shares of the company’s stock worth $5,956,000 after acquiring an additional 98,243 shares in the last quarter. Finally, Millennium Management LLC increased its stake in Nu Skin Enterprises by 100.5% in the second quarter. Millennium Management LLC now owns 534,579 shares of the company’s stock valued at $5,634,000 after acquiring an additional 267,965 shares during the last quarter. Institutional investors own 82.84% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have weighed in on NUS shares. Citigroup cut their target price on Nu Skin Enterprises from $11.50 to $6.75 and set a “neutral” rating for the company in a research note on Tuesday, October 22nd. StockNews.com upgraded Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Monday, November 11th.

Nu Skin Enterprises Trading Down 2.4 %

NYSE NUS opened at $6.87 on Friday. The firm has a market capitalization of $341.51 million, a PE ratio of -3.32 and a beta of 1.20. The business’s 50-day moving average price is $6.98 and its two-hundred day moving average price is $8.79. The company has a current ratio of 1.93, a quick ratio of 1.20 and a debt-to-equity ratio of 0.53. Nu Skin Enterprises, Inc. has a 12 month low of $5.95 and a 12 month high of $20.75.

Nu Skin Enterprises Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, December 11th. Investors of record on Friday, November 29th were given a dividend of $0.06 per share. The ex-dividend date of this dividend was Friday, November 29th. This represents a $0.24 annualized dividend and a dividend yield of 3.49%. Nu Skin Enterprises’s payout ratio is -11.59%.

Nu Skin Enterprises Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.